Ads
related to: sample cv of a ceo of a company template examples
Search results
Results From The WOW.Com Content Network
President and chief executive officer [55] 2015 25 years with HP 2021-04-11 Honeywell: Darius Adamczyk: Chairman, President, and CEO [56] 2017 Succeeded David M. Cote (now the executive chairman) 2017-11-13 HSBC: Noel Quinn: Group CEO [57] 2019 Succeeded John Flint. 2017-11-13 IBM: Arvind Krishna: Chairman, president and CEO [58] 2020 Succeeded ...
Example of the type of extensive CV used in academia, in this case 69 pages long. In English, a curriculum vitae (English: / ... ˈ v iː t aɪ,-ˈ w iː t aɪ,-ˈ v aɪ t iː /, [a] [1] [2] [3] Latin for 'course of life', often shortened to CV) is a short written summary of a person's career, qualifications, and education.
An example of a résumé with a common format with the name John Doe. A résumé or resume (or alternatively resumé), [a] [1] is a document created and used by a person to present their background, skills, and accomplishments. Résumés can be used for a variety of reasons, but most often are used to secure new jobs, whether in the same ...
When using this template, you can change the CEO on Wikidata: Click the edit pencil to go to Wikidata; Remove the old CEO by setting an "end time" qualifier ("edit" their entry in the CEO section, and click "add qualifier"). If you don't know when they stopped being CEO, click the three boxes (to the left of the text input) and set "unknown value".
In March 2000, Dimon became CEO of Bank One, the nation's fifth largest bank. [20] When JPMorgan Chase merged with Bank One in July 2004, Dimon became president and chief operating officer of the combined company. On December 31, 2005, he was named CEO of JPMorgan Chase, and on December 31, 2006, he was named chairman and president. [21]
William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023. [1] [2]Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche's Pharmaceuticals Division from 2019 to 2022.